Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Hookipa Pharma logo

Hookipa Pharma

Recent Finacing

Equity

Recent Raise

$21.3M

HOOKIPA Pharma is a clinical-stage biotechnology company developing VaxWave and TheraT arenavirus-based vaccine platforms to elicit CD8+ T cells and antibodies, advancing CMV and oncology programs with Gilead collaborations.

Founded 2011
New York, United States
101-250
Publicly Traded
hookipapharma.com

Highlights

Focus Areas

Biotechnology
Clinical Trials
Oncology
Therapeutics

Recent Investors

Sofinnova Partners logo
Forbion logo
Gilead Sciences logo
Takeda Ventures logo
Boehringer Ingelheim logo
BioMedPartners logo
HBM Partners logo
Sirona Capital logo
H
Samsara BioCapital logo
Invus logo
Redmile Group logo

Financials

$154.6M

Total Raised

5

Funding rounds

12

Investors


Team

Upgrade to view the team

See the team members at Hookipa Pharma.